- Home
- DTF vs PETS Comparison
DTF vs PETS Comparison
Compare DTF & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTF
- PETS
- Stock Information
- Founded
- DTF 1991
- PETS 1996
- Country
- DTF United States
- PETS United States
- Employees
- DTF N/A
- PETS N/A
- Industry
- DTF Investment Managers
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- DTF Finance
- PETS Consumer Staples
- Exchange
- DTF Nasdaq
- PETS Nasdaq
- Market Cap
- DTF 78.7M
- PETS 70.4M
- IPO Year
- DTF N/A
- PETS N/A
- Fundamental
- Price
- DTF $11.21
- PETS $3.77
- Analyst Decision
- DTF
- PETS Sell
- Analyst Count
- DTF 0
- PETS 2
- Target Price
- DTF N/A
- PETS $3.35
- AVG Volume (30 Days)
- DTF 21.1K
- PETS 163.8K
- Earning Date
- DTF 01-01-0001
- PETS 08-05-2025
- Dividend Yield
- DTF 3.64%
- PETS N/A
- EPS Growth
- DTF N/A
- PETS N/A
- EPS
- DTF 0.44
- PETS 0.02
- Revenue
- DTF N/A
- PETS $247,010,000.00
- Revenue This Year
- DTF N/A
- PETS N/A
- Revenue Next Year
- DTF N/A
- PETS N/A
- P/E Ratio
- DTF $24.34
- PETS $220.93
- Revenue Growth
- DTF N/A
- PETS N/A
- 52 Week Low
- DTF $10.29
- PETS $2.90
- 52 Week High
- DTF $11.19
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- DTF 50.63
- PETS 59.64
- Support Level
- DTF $11.18
- PETS $3.00
- Resistance Level
- DTF $11.23
- PETS $3.60
- Average True Range (ATR)
- DTF 0.03
- PETS 0.19
- MACD
- DTF -0.00
- PETS 0.08
- Stochastic Oscillator
- DTF 30.00
- PETS 70.00
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.